The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – a systematic review of register-based studies
Abstract
Background: Numerous treatment guidelines recommend that long-term use of benzodiazepines (BZD) should be avoided primarily due to development of tolerance and a risk for BZD dependence. Despite this, long-term BZD use remains a controversial subject in clinical patient care with “for and against” debates. However, there is no explicit understanding of what is meant by long-term BZD use in real world. The aim of this study was to assess different definitions, usage patterns, prevalence and other characteristics of long-term BZD use based on published register-based studies. Synthesis of these characteristics is essential to derive a meaningful definition of long-term BZD. Methods: Systematic review of register-based studies on long-term BZD use published in 1994–2014. Results: Fourty-one studies met our predetermined inclusion criteria. The length of BZD use defined as “long-term” varied in these studies ranging from one month to several years. The most common definition was six months or longer during a year. The prevalence of long-term BZD use in the general population was estimated to be about 3%. The relative proportion of long-term BZD users (all definitions) in adult BZD users ranged from 6% to 76% (mean 24%; 95% CL 13–36%). The estimates were higher in studies only on the elderly (47%; 95% CL 31–64%). Long-term use involved typically steady treatment with low BZD doses. However, in elderly patients long-term BZD use and exceeding recommended doses was relatively common. Several characteristics associated with long-term use were found. Conclusions: Long-term BZD use is common and a clinical reality. Uniform definitions for “long-term”, which is in line with population-based evidence, is needed to have more comparable results between studies. Our systematic review suggests that duration of BZD treatment over six months, the most common definition for long-term BZD use in the included studies. As also recommended previously, it is a useful starting point for further analyses on disadvantages but also potential advantages associated with long-term BZD use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiss, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,277
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
JBI's Systematic Reviews: Study Selection and Critical Appraisal
Porritt, K., Gomersall, J., & Lockwood, C. (2014) · AJN, American Journal of Nursing · doi:10.1097/01.naj.0000450430.97383.64 · Cited by 644
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
Benzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Motheral, B., Brooks, J., Clark, M. A., Crown, W. H., Davey, P., Hutchins, D., Martin, B. C., & Stang, P. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00242.x · Cited by 412
Benzodiazepine harm: how can it be reduced?
Lader, M. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04418.x · Cited by 359
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis
Barker, M. (2004) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00096-9 · Cited by 307 · cited 2×
“Does it mean use defined by the development of tolerance, use beyond the recommended period in guidelines or use longer than an arbitrary time limit, such as one year? Regardless of extensive research on long-term BZD use, the existing evidence is difficult to evaluate because of conflicting results, study designs and…”
BackgroundPolypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia
Tiihonen, J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1532 · Cited by 253
Self-citationBenzodiazepines: Risks and Benefits. A Reconsideration
Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113503509 · Cited by 249
Benzodiazepines for schizophrenia
Dold, M., Li, C., Tardy, M., Khorsand, V., Gillies, D., & Leucht, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006391.pub2 · Cited by 169
Usage of benzodiazepines: A review
Donoghue, J., & Lader, M. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500903447810 · Cited by 156 · cited 1×
“Among long-term users, the risks of serious adverse effects, such as psychomotor impairment and the decline of cognitive function, particularly among the aged, are increased [1,8].”
BackgroundLopez-Munoz, F. J., Álamo, C., & García‐García, P. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.01.002 · Cited by 153
Potentially inappropriate prescribing among older people in the United Kingdom
Bradley, M. C., Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T. J., Fahey, T. P., & Hughes, C. M. (2014) · BMC Geriatrics · doi:10.1186/1471-2318-14-72 · Cited by 147
Fang, S., Chen, C., Chang, I., Wu, E. C., Chang, C., & Lin, K. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.017 · Cited by 134
Petitjean, S., Ladewig, D., Meier, C. R., Amrein, R., & Wiesbeck, G. A. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328105e0f2 · Cited by 132
Mugunthan, K., McGuire, T., & Glasziou, P. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x593857 · Cited by 123
Cunningham, C. M., Hanley, G. E., & Morgan, S. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.03.008 · Cited by 121
Egan, M. Y., Moride, Y., Wolfson, C. M., & Monette, J. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04758.x · Cited by 110
Problems and Pitfalls in the Use of Benzodiazepines in the Elderly
Kruse, W. (1990) · Drug Safety · doi:10.2165/00002018-199005050-00003 · Cited by 110
Different study criteria affect the prevalence of benzodiazepine use
Zandstra, S. M., Furer, J. W., van de Lisdonk, E. H., Hof, M. V., Bor, J. H., van Weel, C., & Zitman, F. G. (2002) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270200006 · Cited by 109
Lack of Relationship Between Long-Term Use of Benzodiazepines and Escalation to High Dosages
Soumerai, S. B., Simoni-Wastila, L., Singer, C., Mah, C., Gao, X., Salzman, C., & Ross-Degnan, D. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.7.1006 · Cited by 104 · cited 2×
“Four of the five studies assessing dose escalation found it relatively rare [19,40,46,54] with prevalence of 0.”
BackgroundIsacson, D. G. L. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00296-1 · Cited by 103
High concordance between self-reported medication and official prescription database information
Haukka, J. K., Suvisaari, J., Tuulio‐Henriksson, A., & Lönnqvist, J. K. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0349-6 · Cited by 102
Self-citationPredictors of chronic benzodiazepine use in a health maintenance organization sample
Simon, G. E., VonKorff, M., Barlow, W. E., Pabiniak, C. J., & Wagner, E. H. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00139-4 · Cited by 102
Determinants of chronic benzodiazepine use in the elderly: A longitudinal study
Luijendijk, H. J., Tiemeier, H. W., Hofman, A., Heeringa, J., & Stricker, B. H. C. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03060.x · Cited by 101
Evaluation and implementation of public health registries.
Solomon, D., HENRY, R. C., Hogan, J. G., Amburg, H. V., & Taylor, J. (1991) · Europe PMC (PubMed Central) · Cited by 100
Smith, A. J., & Tett, S. E. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-321 · Cited by 96
Twenty‐year trends in benzodiazepine dispensing in the A ustralian population
Islam, M. M., Conigrave, K. M., Day, C., Nguyen, Y., & Haber, P. (2013) · Internal Medicine Journal · doi:10.1111/imj.12315 · Cited by 82
Drug utilization statistics for individual-level pharmacy dispensing data
Hallas, J. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1063 · Cited by 81
Initiation of Benzodiazepines in the Elderly After Hospitalization
Bell, C. M., Fischer, H. D., Gill, S. S., Zagorski, B., Sykora, K., Wodchis, W. P., Herrmann, N., Bronskill, S. E., Lee, P. E., Anderson, G., et al. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0194-4 · Cited by 79
What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population
Neutel, C. I., Skurtveit, S. O., & Berg, C. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2011.12.014 · Cited by 72
Benzodiazepine prescribing in elderly Australian general practice patients
Windle, A., Elliot, E., Duszynski, K. M., & Moore, V. (2007) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2007.00091.x · Cited by 71
Leikola, S. N. S., Dimitrow, M. S., Lyles, A., Pitkälä, K. H., & Airaksinen, M. S. A. (2011) · Drugs & Aging · doi:10.2165/11586890-000000000-00000 · Cited by 71
Self-citationCharacteristics associated with benzodiazepine usage in elderly outpatients in Taiwan
Cheng, J., Huang, W., Lin, K., & Shih, Y. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1950 · Cited by 70
Tyrer, P. J. (1980) · The British Journal of Psychiatry · doi:10.1192/bjp.137.6.576 · Cited by 69
Effectiveness of benzodiazepines: do they work or not?
Lader, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.8.1189 · Cited by 63 · cited 2×
“This inconsistency between clinical recommendations and practice has been much investigated and debated among health professionals as well as at societal level [3,6].”
BackgroundPerforming Systematic Literature Reviews With Novices: An Iterative Approach
Lavallée, M., Robillard, P. N., & Mirsalari, R. (2014) · IEEE Transactions on Education · doi:10.1109/te.2013.2292570 · Cited by 56
Zandstra, S. M. (2004) · Family Practice · doi:10.1093/fampra/cmh309 · Cited by 56
Longitudinal patterns of new Benzodiazepine use in the elderly
Bartlett, G., Abrahamowicz, M., Tamblyn, R. M., Grad, R. M., Čapek, R., & du Berger, R. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.908 · Cited by 55
Préville, M., Bossé, C., Vasiliadis, H., Voyer, P., Laurier, C., Berbiche, D., Pérodeau, G., Grenier, S., Béland, S., Dionne, P.-A., et al. (2012) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980812000232 · Cited by 52
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage
Victorri-Vigneau, C., Feuillet, F., Wainstein, L., Grall-Bronnec, M., Pivette, J., Chaslerie, A., Sébille, V., & Jolliet, P. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1557-x · Cited by 49
Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.
van Hulten, R. P., Leufkens, H. G. M., & Bakker, A. (1998) · Pharmacy World & Science · doi:10.1023/a:1008636707219 · Cited by 49
Fisher, J. E., Sanyal, C., Frail, D. M., & SKETRIS, I. S. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01245.x · Cited by 49
Comparing patterns of long‐term benzodiazepine use between a Dutch and a Swedish community
van Hulten, R. P., Isacson, D. G. L., Bakker, A., & Leufkens, H. G. M. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.784 · Cited by 49
Benzodiazepine Use in Older Adults Enrolled in a Health Maintenance Organization
Gray, S. L., Eggen, A. E., Blough, D. K., Buchner, D. M., & LaCroix, A. Z. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200309000-00012 · Cited by 44
Tolerance to benzodiazepines among long-term users in primary care
Willems, I. A. T., Gorgels, W. J. M. J., Voshaar, R. C. O., Mulder, J., & Lucassen, P. L. (2013) · Family Practice · doi:10.1093/fampra/cmt010 · Cited by 44
Benzodiazepine use and risk of stroke: A retrospective population‐based cohort study
Huang, W., Muo, C., Chang, S., Chang, Y., Tsai, C., & Kao, C. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12117 · Cited by 34
Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks
Starčević, V. (2012) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.110.008631 · Cited by 34
Hsiao, F., Hsieh, P.-H., & Gau, C. (2013) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2012.12.001 · Cited by 34
Andersen, A. B. T., & Frydenberg, M. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2104 · Cited by 33
Nordfjærn, T. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.05.017 · Cited by 32
Bocquier, A., Bezzou, K., Nauleau, S., & Verger, P. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00587.x · Cited by 31
Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up
van Hulten, R., Teeuw, K. B., Bakker, A., & Leufkens, H. G. M. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0548-0 · Cited by 31
Prescribing benzodiazepines for noninstitutionalized elderly.
Thomson, M., & Smith, W. A. (1995) · PubMed Central · Cited by 27
Uncovering the source of new benzodiazepine prescriptions in community‐dwelling older adults’
Halme, A. S., Béland, S., Préville, M., & Tannenbaum, C. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3818 · Cited by 25
Benzodiazepine use in Denmark 1997–2008
Holm, E., Fosbøl, E. L., Pedersen, H., Jensen, T. B., Nielsen, M. B., Weeke, P. E., Brinth, L. S., & Torp-Pedersen, C. (2012) · European Geriatric Medicine · doi:10.1016/j.eurger.2012.04.007 · Cited by 25
The impact of hospitalisation on the initiation and long-term use of benzodiazepines
Stuffken, R., van Hulten, R., Heerdink, E. R., Movig, K. L. L., & Egberts, T. C. G. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0918-5 · Cited by 22
Hochverbrauch von Zolpidem und Zopiclon: Querschnittsstudie auf Basis von Krankenkassendaten
Hoffmann, F., Pfannkuche, M., & Glaeske, G. (2008) · Der Nervenarzt · doi:10.1007/s00115-007-2280-6 · Cited by 21
Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway
Kjosavik, S. R., Ruths, S., & Hunskaar, S. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1124-2 · Cited by 21
Langzeitverschreibung von Benzodiazepinen und Non-Benzodiazepinen
Verthein, U., Martens, M., Raschke, P., & Holzbach, R. (2012) · Das Gesundheitswesen · doi:10.1055/s-0032-1321756 · Cited by 21
Rojas‐Fernandez, C. H., Carver, D., & Tonks, R. S. (1999) · PubMed · Cited by 19
Sund, R. (2008) · Työväentutkimus Vuosikirja · Cited by 19
Yeh, H.-H. H., Chen, C., Fang, S., Chang, I., Wu, E. C., & Lin, K. (2011) · Psychiatric Services · doi:10.1176/appi.ps.62.8.900 · Cited by 19
An association between benzodiazepine use and occurrence of benign brain tumors
Harnod, T., Lin, C., Sung, F., & Kao, C. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.11.009 · Cited by 18
Benzodiazepines Consumption: Does Dependence Vary with Age?
Gérardin, M., Victorri‐Vigneau, C., Guerlais, M., Guillou-Landréat, M., Grall‐Bronnec, M., & Jolliet, P. (2014) · Substance Use & Misuse · doi:10.3109/10826084.2014.912226 · Cited by 18
Tvete, I. F., Bjørner, T., Aursnes, I., & Skomedal, T. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003296 · Cited by 18
In-depth investigation for prescribing trends of benzodiazepines in South Korea
Oh, S.-H., Oh, K., Lee, K., Woo, J., Lee, B.-C., Hwang, J., Park, E., Kwak, S. J., & Kwon, J. (2014) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp202008 · Cited by 17
Nomura, K., Nakao, M., Sato, M., & Yano, E. (2007) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.212.239 · Cited by 14
van Eijk, J. T. M., Bosma, H., Jonkers, C. C. M., Lamers, F., & Muijrers, P. E. M. (2010) · Depression Research and Treatment · doi:10.1155/2010/105931 · Cited by 14
The basic pharmacoepidemiology of benzodiazepine use in Norway 2004-9
Bramness, J. G., & Sexton, J. A. (2011) · Norsk Epidemiologi · doi:10.5324/nje.v21i1.1423 · Cited by 13
Hypnotic prescription without face to face contact: A report from French family medicine
Rat, C., Werner, E. L., Pivette, J., Senand, R., & Nguyen, J. (2013) · European Journal of General Practice · doi:10.3109/13814788.2013.777423 · Cited by 10
Logan, K., & Lawrie, S. M. (1994) · BMJ · doi:10.1136/bmj.309.6956.742a · Cited by 9
Modelling the consumption of anxiolytics and its addictive behaviour
Olmeda, M. N. G., Martínez, I. B., de la Poza, E., Vivas-Consuelo, D., & Caballer‐Tarazona, M. (2011) · Mathematical and Computer Modelling · doi:10.1016/j.mcm.2010.12.036 · Cited by 5
A descriptive study of anxiolytic and hypnotic prescribing according to age and sex
Kairuz, T. E., & Truter, I. (2007) · International Journal of Pharmacy Practice · doi:10.1211/ijpp.15.4.0008 · Cited by 4
Key considerations for long-term studies with anxiolytics
PLACCHI, M. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)85180-7 · Cited by 2
Cited by
Treatment of Benzodiazepine Dependence
Soyka, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1611832 · Cited by 465
Clinical Practice Guideline: Ménière’s Disease
Basura, G. J., Adams, M. E., Monfared, A., Schwartz, S. R., Antonelli, P. J., Burkard, R., Bush, M. L., Bykowski, J., Colandrea, M., Derebery, J., et al. (2020) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599820909438 · Cited by 316
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Implementation Science · doi:10.1186/s13012-022-01206-7 · Cited by 62
Chapoutot, M., Peter-Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R., Siclari, F., Nicolas, A., Lemoine, P., Higgins, S., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910222 · Cited by 59
“Since addiction occurs within the first month of use [12], the legal prescription period is often exceeded [9,13,14].”
BackgroundTakaesu, Y., Utsumi, T., Okajima, I., Shimura, A., Kotorii, N., Kuriyama, K., Yamashita, H., Suzuki, M., Watanabe, N., & Mishima, K. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101214 · Cited by 57
Metadata
- Authors
- Kurko, T. A. T., Saastamoinen, L. K., Tähkäpää, S., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M. S., & Hietala, J.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-11
- Volume
- 30
- Issue
- 8
- Pages
- 1037-1047
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2184235991
- Cited by
- 280
- References
- 79
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.